Mrv0541 02231216162D 19 19 0 0 0 0 999 V2000 3.7935 -1.9842 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 4.5080 3.3784 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 5.9370 4.2035 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.3645 -1.9842 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 5.9370 3.3784 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 3.7935 0.4909 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.5080 0.9034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.7935 -0.3341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.5080 1.7284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0791 -0.7466 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.2224 2.1409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0791 -1.5717 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.2224 2.9659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3645 -2.8092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0791 -3.2217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6500 -3.2217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0791 -4.0467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6500 -4.0467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3645 -4.4592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 12 2 0 0 0 0 2 13 2 0 0 0 0 3 5 1 0 0 0 0 4 12 1 0 0 0 0 4 14 1 0 0 0 0 5 13 1 0 0 0 0 6 7 1 0 0 0 0 6 8 1 0 0 0 0 7 9 1 0 0 0 0 8 10 1 0 0 0 0 9 11 1 0 0 0 0 10 12 1 0 0 0 0 11 13 1 0 0 0 0 14 15 2 0 0 0 0 14 16 1 0 0 0 0 15 17 1 0 0 0 0 16 18 2 0 0 0 0 17 19 2 0 0 0 0 18 19 1 0 0 0 0 M END > DB02546 > drugbank > ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1 > InChI=1S/C14H20N2O3/c17-13(15-12-8-4-3-5-9-12)10-6-1-2-7-11-14(18)16-19/h3-5,8-9,19H,1-2,6-7,10-11H2,(H,15,17)(H,16,18) > InChIKey=WAEXFXRVDQXREF-UHFFFAOYSA-N > 3 > 28.386758455309753 > 1 > 3 > 264.147392516 > 0 > C14H20N2O3 > 1 > N-hydroxy-N'-phenyloctanediamide > 1.88 > 2.003969249333333 > -3.57 > 264.3202 > 0 > 1 > 0 > 14.203978435931308 > 8.90753598024551 > -3.521337304210903 > 78.43 > 73.80510000000002 > 8 > 1 > 7.16e-02 g/l > vorinostat > 0 > DB02546 > approved; investigational > Vorinostat > Octanedioic acid hydroxyamide phenylamide; SAHA; SHH; Suberanilohydroxamic acid; Suberoylanilide hydroxamic acid > Zolinza $$$$